1239908-20-3
1239908-20-3
Chemical Structure
Ixazomib citrate
Synonym(s): MLN9708
- CAS No.: 1239908-20-3
- Formula:C20H23BCl2N2O9
- Molecular Weight:517.12
IUPAC Name: (R)-2,2'-(2-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid
InChIKey: MBOMYENWWXQSNW-AWEZNQCLSA-N
SMILES: O=C(O)CC1(CC(O)=O)OB([C@@H](NC(CNC(C2=CC(Cl)=CC=C2Cl)=O)=O)CC(C)C)OC1=O
Biological Activity: Ixazomib citrate (MLN9708) is a selective, orally active, second-generation proteasome inhibitor. Ixazomib citrate can be used for the study of a broad range of human malignancies[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ixazomib citrate | 99.87% | Ixazomib citrate (MLN9708) is a selective, orally active, second-generation proteasome inhibitor. Ixazomib citrate can be used for the study of a broad range of human malignancies. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ixazomib citrate (Standard) | ≥98% | Ixazomib citrate (Standard) is the analytical standard of Ixazomib citrate (HY-10452). This product is intended for research and analytical applications. Ixazomib citrate (MLN9708) is a selective, orally active, second-generation proteasome inhibitor. Ixazomib citrate can be used for the study of a broad range of human malignancies. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
